 By David Bautz, PhD NASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update Four Abstracts Published in 30th ECCMID Abstract Book On May 11, 2020, ContraFect Corp. NASDAQ:CFRX announced four abstracts were published in the 30th European Congress of Clinical Microbiology and Infectious Diseases ECCMID abstract book. Both the on-site and online portion of ECCMID 2020 were cancelled due 